Enzyme immunoassay for the quantitative determination of free Trastuzumab (Herceptin®, Herclon®) in serum and plasma.
The solid phase (MTP) is coated by the target molecule, in this case HER2/neu receptor.
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Herceptin® and Herclon® are trademarks Genentech Inc